<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02392585</url>
  </required_header>
  <id_info>
    <org_study_id>ATAUNİ23</org_study_id>
    <nct_id>NCT02392585</nct_id>
  </id_info>
  <brief_title>Single or Triple Uterine Tourniquet at Myomectomy</brief_title>
  <official_title>Triple Tourniquet vs. Single Tourniquet to Reduce Haemorrhage During Myomectomy: a Prospective Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ragıp Atakan Al</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ataturk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of study is to compare triple tourniquet vs. single tourniquet to reduce blood loss
      at open myomectomy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Estimated blood loss at the end of myomectomy</measure>
    <time_frame>15 minutes postoperatively</time_frame>
    <description>Surgical blood loss will be estimated by sum of the volume of suction fluid and blood loss quantitated by gravimetric method.
Suction fluid will be measured at the end of operation and volume of irrigation fluid will be subtracted from total suction volume.
◦Surgical drapes, sponges and towels will be weighted before and just after surgery. The blood loss will be estimated as differences in gram by weighing when 1ml blood supposed as 1.06 gr.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The amount of transfusions</measure>
    <time_frame>7 Days</time_frame>
    <description>Erythrocyte transfusions will be allowed when haemoglobin dropped below 8 g/dL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>A change in hemoglobin</measure>
    <time_frame>At baseline and 48 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume in drains</measure>
    <time_frame>7 days</time_frame>
    <description>Drain will be removed when discharge drops below 50 ml/day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peri-operative complications</measure>
    <time_frame>6 weeks</time_frame>
    <description>Including but not limited to fever, pelvic infections, wound infections.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total operation time</measure>
    <time_frame>5 minutes post operatively</time_frame>
    <description>Skin to skin operation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tourniquet time</measure>
    <time_frame>5 minutes after tourniquet removed</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Anti-Mullerian Hormone levels variation</measure>
    <time_frame>One year postoperatively</time_frame>
    <description>Anti-Mullerian Hormone levels before surgery, 6 months and 12 months after surgery</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Uterine Myoma</condition>
  <arm_group>
    <arm_group_label>Single tourniquet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Triple tourniquet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single tourniquet</intervention_name>
    <description>Single tourniquet is tourniquet applied uterine isthmus to occlude the uterine arteries. For this purpose, a small opening is made in the avascular place of the broad ligament on either side of the uterine isthmus superior to the uterine vessels. A pediatric Foley catheter is threaded through the two holes and tied tightly anteriorly around the cervix at the level of the internal os.</description>
    <arm_group_label>Single tourniquet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Triple tourniquet</intervention_name>
    <description>Triple tourniquet consist of two tourniquet applied both infundibulopelvic ligaments and one uterine isthmus to occlude the left and right ovarian vessels and to occlude the uterine arteries. For this purpose, a small opening is made in the avascular place of the broad ligament on either side of the uterine isthmus superior to the uterine vessels. A pediatric Foley catheter is threaded through the two holes and tied tightly anteriorly around the cervix at the level of the internal os.
Through the same openings in the broad ligament each side a Foley catheter looped around the infundibulopelvic ligament lateral to the fallopian tube and ovary.</description>
    <arm_group_label>Triple tourniquet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Three or more uterine myoma

          2. At least one myoma ≥ 8 cm, if there is less than three myoma

        Exclusion Criteria:

          1. Pedunculated myoma,

          2. broad ligament myoma
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neset Gümüsburun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ataturk University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Atatürk Üniversitesi Araştırma Hastanesi</name>
      <address>
        <city>Erzurum</city>
        <zip>25240</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2015</study_first_submitted>
  <study_first_submitted_qc>March 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2015</study_first_posted>
  <last_update_submitted>May 28, 2016</last_update_submitted>
  <last_update_submitted_qc>May 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ataturk University</investigator_affiliation>
    <investigator_full_name>Ragıp Atakan Al</investigator_full_name>
    <investigator_title>Assoc.Prof</investigator_title>
  </responsible_party>
  <keyword>Leiomyoma of uterus</keyword>
  <keyword>Hemostasis, Surgical</keyword>
  <keyword>Prevention of Surgical Blood Loss</keyword>
  <keyword>mechanical uterine tourniquet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

